These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 18535887

  • 1. FDG positron emission tomography imaging of drug-induced pneumonitis.
    Morikawa M, Demura Y, Mizuno S, Ameshima S, Ishizaki T, Okazawa H.
    Ann Nucl Med; 2008 May; 22(4):335-8. PubMed ID: 18535887
    [Abstract] [Full Text] [Related]

  • 2. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT, Hu C, Chiu YL, Peng NJ, Liu RS.
    PLoS One; 2014 May; 9(12):e115127. PubMed ID: 25517451
    [Abstract] [Full Text] [Related]

  • 3. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE, Grigsby PW, Siegel BA, Dehdashti F, Moley JF, Hall BL.
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary drug toxicity: FDG-PET findings in patients with lymphoma.
    Kazama T, Faria SC, Uchida Y, Ito H, Macapinlac HA.
    Ann Nucl Med; 2008 Feb; 22(2):111-4. PubMed ID: 18311535
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased pulmonary FDG uptake in bleomycin-associated pneumonitis.
    von Rohr L, Klaeser B, Joerger M, Kluckert T, Cerny T, Gillessen S.
    Onkologie; 2007 Jun; 30(6):320-3. PubMed ID: 17551256
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors].
    Wu ZJ, Zhang YX, Wei H, Jia Q.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2253-6. PubMed ID: 18001544
    [Abstract] [Full Text] [Related]

  • 11. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
    Frank A, Lefkowitz D, Jaeger S, Gobar L, Sunderland J, Gupta N, Scott W, Mailliard J, Lynch H, Bishop J.
    Int J Radiat Oncol Biol Phys; 1995 Jul 30; 32(5):1495-512. PubMed ID: 7635795
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
    Plaza MJ, Collado-Mesa F, Bokhoor J, Alperin N, Yepes MM.
    Breast J; 2014 Jul 30; 20(3):235-42. PubMed ID: 24750508
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study.
    Pinker K, Bogner W, Baltzer P, Karanikas G, Magometschnigg H, Brader P, Gruber S, Bickel H, Dubsky P, Bago-Horvath Z, Bartsch R, Weber M, Trattnig S, Helbich TH.
    Clin Cancer Res; 2014 Jul 01; 20(13):3540-9. PubMed ID: 24963052
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.